These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. URETHANE GEL REACTION IN DIAGNOSIS OF MULTIPLE MYELOMA AND MACROGLOBULINEMIA. KYLE RA; MCGUCKIN WF Am J Clin Pathol; 1965 Feb; 43():157-60. PubMed ID: 14253119 [No Abstract] [Full Text] [Related]
3. [M-COMPONENTS IN SERUM. A 4-YEAR MATERIAL FROM A COUNTY GENERAL HOSPITAL]. HALLEN A Nord Med; 1964 Dec; 72():1501-4. PubMed ID: 14225505 [No Abstract] [Full Text] [Related]
4. [URETHANE GEL REACTION IN THE DIAGNOSIS OF KAHLER'S DISEASE]. PINTO AS; RODEIA MI Arq Patol; 1964 Dec; 36():95-7. PubMed ID: 14304673 [No Abstract] [Full Text] [Related]
5. Macroglobulinemia and myelomatosis. ADNER PL; WALLENIUS G; WERNER I Acta Med Scand; 1960 Dec; 168():431-7. PubMed ID: 13681516 [No Abstract] [Full Text] [Related]
6. MYELOMATOSIS. A CLINICAL AND BIOCHEMICAL STUDY OF 105 CASES. DRIVSHOLM A Acta Med Scand; 1964 Oct; 176():509-24. PubMed ID: 14221661 [No Abstract] [Full Text] [Related]
7. THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS. ALPER CA; FREEMAN T; WALDENSTROEM J J Clin Invest; 1963 Dec; 42(12):1858-68. PubMed ID: 14086772 [No Abstract] [Full Text] [Related]
8. TURNOVER RATE OF PARAPROTEINS IN MYELOMATOSIS. STUDIES ON THE TURNOVER RATE OF SERUM PARAPROTEINS AFTER LABELLING IN VIVO, WITH SPECIAL REFERENCE TO REPEATED TURNOVER-RATE DETERMINATIONS. DRIVSHOLM A Acta Med Scand; 1964 Sep; 176():257-67. PubMed ID: 14208918 [No Abstract] [Full Text] [Related]
10. Blood volume and hematocrit value in macroglobulinemia and myeloma. Kopp WL; MacKinney AA; Wasson G Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452 [No Abstract] [Full Text] [Related]
11. Multiple myeloma and macroglobulinemia. Advances in treatment. Ruiz VG; Alexanian R Postgrad Med; 1974 May; 55(5):179-85. PubMed ID: 4212181 [No Abstract] [Full Text] [Related]
15. Serum beta-lipoprotein and other specific protein concentrations in patients with immunocytoma. Shulman G; Lynch SR; Bezwoda WR; Gilich GC J Clin Pathol; 1976 May; 29(5):458-61. PubMed ID: 180062 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of malignant gammopathies]. Emmerich B Dtsch Med Wochenschr; 1984 Jan; 109(1):26-30. PubMed ID: 6420138 [No Abstract] [Full Text] [Related]
17. Attempt at treatment of 21 patients with myeloma or macroglobulinemia with p-di-2-chlorethylamino-1-phenylalanine (melphalan). BERNARD J; SELIGMANN M; DANON F Nouv Rev Fr Hematol; 1962; 2():611-6. PubMed ID: 13970996 [No Abstract] [Full Text] [Related]
18. [Lymphoid-plasmocytic myeloma with protein-chemical particularities (atypical macroglobulinemia)]. STOBBE H Z Gesamte Inn Med; 1955 Jun; 10(12):590-6. PubMed ID: 13257354 [No Abstract] [Full Text] [Related]
19. Starch gel electrophoresis of serum proteins and urinary proteins from patients with multiple myeloma, macroglobulinemia, and other forms of dysproteinemia. Demonstration of diversity and complexity of protein alterations in 72 cases. ENGLE RL; WOODS KR; CASTILLO GB; PERT JH J Lab Clin Med; 1961 Jul; 58():1-22. PubMed ID: 13696888 [No Abstract] [Full Text] [Related]
20. Treatment of multiple myeloma and macroglobulinemai Waldenström: A long-term follow-up study. Onodera S; Otaki M; Oikawa K; Mikami M; Sato I Tohoku J Exp Med; 1975 Aug; 116(4):317-25. PubMed ID: 810919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]